特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
691697

呼吸器疾患治療薬の世界市場:成長動向と競合分析:2018年~2025年

Global Respiratory Drugs Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

出版日: | 発行: QYResearch | ページ情報: 英文 119 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
呼吸器疾患治療薬の世界市場:成長動向と競合分析:2018年~2025年
出版日: 2018年09月04日
発行: QYResearch
ページ情報: 英文 119 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の呼吸器疾患治療薬市場を調査し、市場の概要、タイプ・用途・地域別の市場動向、売上数・収益額の推移と予測(過去5年、今後8年間分)、市場シェア、市場の成長要因、主要企業のプロファイルなど、包括的な情報を提供しています。

第1章 市場概要

  • 調査範囲
  • 調査対象の製薬企業
  • 市場区分:タイプ別
    • 喘息
    • 慢性閉塞性肺疾患(COPD)
    • 突発性肺線維症(IPF)
    • 嚢胞性繊維症(CF)
  • 市場区分:用途別
    • 病院
    • 外来ケア
    • その他
  • 調査目的
  • 調査期間

第2章 成長動向

  • 市場規模
    • 収益額
    • 売上数
  • 地域別の成長率
  • 産業動向
    • 主な市場動向
    • 市場促進要因

第3章 市場シェア:企業別

  • 呼吸器疾患治療薬の売上数:企業別
    • 売上数の推移
    • 売上シェア
  • 呼吸器疾患治療薬の収益額:企業別
    • 収益額の推移
    • 収益シェア
    • 企業の市場集中度
  • 医薬品価格:企業別
  • 主要企業の生産拠点・工場の分布
  • 主要企業の市場参入時期
  • 主要企業の製品
  • 合併・買収・事業拡大計画

第4章 市場規模:タイプ別

  • 売上数と収益額の推移
  • 売上シェア:タイプ別
  • 収益シェア:タイプ別
  • 価格:タイプ別

第5章 市場規模:用途別

  • 市場概要
  • 売上数:用途別

第6章 北米の呼吸器疾患治療薬市場

  • 市場内訳:企業別
  • 市場内訳:タイプ別
  • 市場内訳:用途別
  • 市場内訳:国別
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の呼吸器疾患治療薬市場

  • 市場内訳:企業別
  • 市場内訳:タイプ別
  • 市場内訳:用途別
  • 市場内訳:国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋の呼吸器疾患治療薬市場

  • 市場内訳:企業別
  • 市場内訳:タイプ別
  • 市場内訳:用途別
  • 市場内訳:国別
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • インドネシア
    • マレーシア
    • フィリピン
    • タイ
    • ベトナム

第9章 中南米の呼吸器疾患治療薬市場

  • 市場内訳:企業別
  • 市場内訳:タイプ別
  • 市場内訳:用途別
  • 市場内訳:国別
    • ブラジル

第10章 中東・アフリカの呼吸器疾患治療薬市場

  • 市場内訳:企業別
  • 市場内訳:タイプ別
  • 市場内訳:用途別
  • 市場内訳:地域/国別
    • 湾岸協力会議(GCC)
    • エジプト
    • 南アフリカ

第11章 企業プロファイル

  • FibroGen
  • Amgen
  • Dr. Reddy's Laboratories
  • Afferent Pharmaceuticals
  • 大日本住友製薬
  • Abbott
  • Horizon Pharma
  • Pfizer

第12章 バリューチェーンと販売チャネルの分析

  • バリューチェーン分析
  • 販売チャネル分析
    • 販売チャネル
    • 流通業者
  • 顧客

第13章 市場予測

  • 売上数と収益額の予測
  • 売上数の予測:タイプ別
  • 売上数の予測:用途別
  • 市場予測:地域別
  • 北米
  • 欧州
  • アジア太平洋
  • 中南米
  • 中東・アフリカ

第14 調査結果と総論

第15章 付録

図表

List of Tables and Figures

  • Figure Respiratory drugs Product Picture
  • Table Respiratory drugs Key Market Segments
  • Table Major Manufacturers Respiratory drugs Covered in This Report
  • Table Global Respiratory drugs Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
  • Figure Global Respiratory drugs Sales Market Shar by Type 2013-2025
  • Figure Asthma Figures
  • Table Major Manufacturers of Asthma
  • Figure Chronic Obstructive Pulmonary Disease Figures
  • Table Major Manufacturers of Chronic Obstructive Pulmonary Disease
  • Figure Idiopathic Pulmonary Fibrosis Figures
  • Table Global Respiratory drugs Market Share by Application 2018-2025 (K Units)
  • Figure Respiratory drugs Report Years Considered
  • Figure Global Respiratory drugs Market Size 2013-2025 (Million US$)
  • Figure Global Respiratory drugs Sales 2013-2018 (K Units)
  • Table Global Respiratory drugs Market Size by Regions 2013-2018 (K Units) & (Million US$)
  • Table Global Respiratory drugs Sales by Regions 2013-2018 (K Units)
  • Table Global Respiratory drugs Sales Market Share by Regions 2013-2018
  • Figure Global Respiratory drugs Sales Market Share by Regions 2013-2018
  • Figure Global Respiratory drugs Sales Market Share by Regions in 2018
  • Table Global Respiratory drugs Revenue by Regions 2013-2018 (Million US$)
  • Table Global Respiratory drugs Revenue Market Share by Regions 2013-2018
  • Figure Global Respiratory drugs Revenue Market Share by Regions 2013-2018
  • Figure Global Respiratory drugs Revenue Market Share by Regions in 2018
  • Table Market Top Trends
  • Table Global Respiratory drugs Sales by Manufacturers (2013-2018) (K Units)
  • Table Global Respiratory drugs Sales Share by Manufacturers (2013-2018)
  • Figure Global Respiratory drugs Sales Share by Manufacturers in 2018
  • Table Respiratory drugs Revenue by Manufacturers (2013-2018) (Million USD)
  • Table Respiratory drugs Revenue Share by Manufacturers (2013-2018)
  • Figure Respiratory drugs Value Share by Manufacturers in 2018
  • Table Global Respiratory drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Manufacturers Respiratory drugs Price (2013-2018) (USD/Unit)
  • Table Key Manufacturers Respiratory drugs Plants/Factories Distribution
  • Table Key Manufacturers Respiratory drugs Area Served
  • Table Date of Key Manufacturers Enter into Respiratory drugs Market
  • Table Key Manufacturers Respiratory drugs Product Type
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Asthma Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global Respiratory drugs Sales by Type (2013-2018) (K Units)
  • Table Global Respiratory drugs Sales Share by Type (2013-2018)
  • Figure Global Respiratory drugs Sales Market Share by Type (2013-2018)
  • Figure Global Respiratory drugs Sales Market Share by Type in 2017
  • Table Global Respiratory drugs Revenue by Type (2013-2018) (Million US$)
  • Table Global Respiratory drugs Revenue Share by Type (2013-2018)
  • Figure Global Respiratory drugs Revenue Market Share by Type (2013-2018)
  • Figure Global Respiratory drugs Revenue Market Share by Type in 2017
  • Table Respiratory drugs Price by Type 2013-2018 (USD/Unit)
  • Table Global Respiratory drugs Sales by Application (2013-2018) (K Units)
  • Table Global Respiratory drugs Sales Share by Application (2013-2018)
  • Figure Global Sales Respiratory drugs Market Share by Application (2013-2018)
  • Figure Global Sales Respiratory drugs Market Share by Application in 2017
  • Figure North America Respiratory drugs Sales Growth Rate 2013-2018 (K Units)
  • Figure North America Respiratory drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table North America Respiratory drugs Sales by Company (2013-2018) (K Units)
  • Table North America Respiratory drugs Sales Market Share by Company (2013-2018)
  • Figure North America Respiratory drugs Sales Market Share by Company in 2018
  • Table North America Respiratory drugs Sales by Type (2013-2018) (K Units)
  • Table North America Respiratory drugs Sales Market Share by Type (2013-2018)
  • Figure North America Respiratory drugs Market Share by Type in 2018
  • Table North America Respiratory drugs Sales by Application (2013-2018) (K Units)
  • Table North America Respiratory drugs Sales Market Share by Application (2013-2018)
  • Figure North America Respiratory drugs Market Share by Application in 2018
  • Table North America Respiratory drugs Sales by Countries (2013-2018) (K Units)
  • Table North America Respiratory drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 North America Respiratory drugs Sales Market Share by Countries
  • Table North America Respiratory drugs Revenue by Countries (2013-2018) (Million US$)
  • Table North America Respiratory drugs Revenue Market Share by Countries (2013-2018)
  • Figure 2017 North America Respiratory drugs Revenue Market Share by Countries
  • Figure United States Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Canada Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Mexico Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Europe Respiratory drugs Sales Growth Rate 2013-2018 (K Units)
  • Figure Europe Respiratory drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Europe Respiratory drugs Sales by Company (2013-2018) (K Units)
  • Table Europe Respiratory drugs Sales Market Share by Company (2013-2018)
  • Figure Europe Respiratory drugs Sales Market Share by Company in 2018
  • Table Europe Respiratory drugs Sales by Type (2013-2018) (K Units)
  • Table Europe Respiratory drugs Sales Market Share by Type (2013-2018)
  • Figure 2017 Europe Respiratory drugs Market Share by Type
  • Table Europe Respiratory drugs Sales by Application (2013-2018) (K Units)
  • Table Europe Respiratory drugs Sales Market Share by Application (2013-2018)
  • Figure 2017 Europe Respiratory drugs Market Share by Application
  • Table Europe Respiratory drugs Sales by Countries (2013-2018) (K Units)
  • Table Europe Respiratory drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 Europe Respiratory drugs Sales Market Share by Countries
  • Table Europe Respiratory drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Europe Respiratory drugs Revenue Market Share by Countries (2013-2018)
  • Figure Europe Respiratory drugs Revenue Market Share by Countries in 2018
  • Figure Germany Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure France Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure UK Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Italy Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Russia Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Asia Pacific Respiratory drugs Sales Growth Rate 2013-2018 (K Units)
  • Figure Asia Pacific Respiratory drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Asia Pacific Respiratory drugs Sales by Company (2013-2018) (K Units)
  • Table Asia Pacific Respiratory drugs Sales Market Share by Company (2013-2018)
  • Figure Asia Pacific Respiratory drugs Sales Market Share by Company in 2018
  • Table Asia Pacific Respiratory drugs Sales by Type (2013-2018) (K Units)
  • Table Asia Pacific Respiratory drugs Sales Market Share by Type (2013-2018)
  • Figure Asia Pacific Respiratory drugs Market Share by Type in 2018
  • Table Asia Pacific Respiratory drugs Sales by Application (2013-2018) (K Units)
  • Table Asia Pacific Respiratory drugs Sales Market Share by Application (2013-2018)
  • Figure Asia Pacific Respiratory drugs Market Share by Application in 2018
  • Table Asia Pacific Respiratory drugs Sales by Countries (2013-2018) (K Units)
  • Table Asia Pacific Respiratory drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Respiratory drugs Sales Market Share by Countries
  • Table Asia Pacific Respiratory drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Asia Pacific Respiratory drugs Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Respiratory drugs Revenue Market Share by Countries
  • Figure China Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure China Respiratory drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Japan Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Japan Respiratory drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Korea Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Korea Respiratory drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure India Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure India Respiratory drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Australia Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Australia Respiratory drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Indonesia Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Indonesia Respiratory drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Malaysia Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Malaysia Respiratory drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Philippines Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Philippines Respiratory drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Thailand Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Thailand Respiratory drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Vietnam Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Vietnam Respiratory drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Central & South America Respiratory drugs Sales Growth Rate 2013-2018 (K Units)
  • Figure Central & South America Respiratory drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Central & South America Respiratory drugs Sales by Company (2013-2018) (K Units)
  • Table Central & South America Respiratory drugs Sales Market Share by Company (2013-2018)
  • Figure Central & South America Respiratory drugs Sales Market Share by Company in 2018
  • Table Central & South America Respiratory drugs Sales by Type (2013-2018) (K Units)
  • Table Central & South America Respiratory drugs Sales Market Share by Type (2013-2018)
  • Figure Central & South America Respiratory drugs Market Share by Type in 2018
  • Table Central & South America Respiratory drugs Sales by Application (2013-2018) (K Units)
  • Table Central & South America Respiratory drugs Sales Market Share by Application (2013-2018)
  • Figure Central & South America Respiratory drugs Market Share by Application in 2018
  • Table Central & South America Respiratory drugs Sales by Countries (2013-2018) (K Units)
  • Table Central & South America Respiratory drugs Sales Market Share by Countries (2013-2018)
  • Figure Central & South America Respiratory drugs Sales Market Share by Countries in 2018
  • Table Central & South America Respiratory drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Central & South America Respiratory drugs Revenue Market Share by Countries (2013-2018)
  • Figure Central & South America Respiratory drugs Revenue Market Share by Countries in 2018
  • Figure Brazil Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Brazil Respiratory drugs Revenue Growth Rate (2013-2018) (K Units)
  • Figure Middle East and Africa Respiratory drugs Sales Growth Rate 2013-2018 (K Units)
  • Figure Middle East and Africa Respiratory drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Middle East and Africa Respiratory drugs Sales by Type (2013-2018) (K Units)
  • Table Middle East and Africa Respiratory drugs Sales Market Share by Type (2013-2018)
  • Figure 2017 Middle East and Africa Respiratory drugs Market Share by Type
  • Table Middle East and Africa Respiratory drugs Sales by Application (2013-2018) (K Units)
  • Table Middle East and Africa Respiratory drugs Sales Market Share by Application (2013-2018)
  • Figure 2017 Middle East and Africa Respiratory drugs Market Share by Application
  • Table Middle East and Africa Respiratory drugs Sales by Countries (2013-2018) (K Units)
  • Table Middle East and Africa Respiratory drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Respiratory drugs Sales Market Share by Countries
  • Table Middle East and Africa Respiratory drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Middle East and Africa Respiratory drugs Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Respiratory drugs Revenue Market Share by Countries
  • Figure GCC Countries Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure GCC Countries Respiratory drugs Revenue Growth Rate (2013-2018) (K Units)
  • Figure Egypt Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Egypt Respiratory drugs Revenue Growth Rate (2013-2018) (K Units)
  • Figure South Africa Respiratory drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure South Africa Respiratory drugs Revenue Growth Rate (2013-2018) (K Units)
  • Table FibroGen Company Details
  • Table FibroGen Description and Business Overview
  • Table FibroGen Respiratory drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table FibroGen Respiratory drugs Sales Growth Rate (2013-2018)
  • Table FibroGen Respiratory drugs Sales Market Share in Global Market
  • Table FibroGen Recent Development
  • Table Amgen Company Details
  • Table Amgen Description and Business Overview
  • Table Amgen Respiratory drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Amgen Respiratory drugs Sales Growth Rate (2013-2018)
  • Table Amgen Respiratory drugs Sales Market Share in Global Market
  • Table Amgen Recent Development
  • Table Dr. Reddy's Laboratories Company Details
  • Table Dr. Reddy's Laboratories Description and Business Overview
  • Table Dr. Reddy's Laboratories Respiratory drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Dr. Reddy's Laboratories Respiratory drugs Sales Growth Rate (2013-2018)
  • Table Dr. Reddy's Laboratories Respiratory drugs Sales Market Share in Global Market
  • Table Dr. Reddy's Laboratories Recent Development
  • Table Afferent Pharmaceuticals Company Details
  • Table Afferent Pharmaceuticals Description and Business Overview
  • Table Afferent Pharmaceuticals Respiratory drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Afferent Pharmaceuticals Respiratory drugs Sales Growth Rate (2013-2018)
  • Table Afferent Pharmaceuticals Respiratory drugs Sales Market Share in Global Market
  • Table Afferent Pharmaceuticals Recent Development
  • Table Dainippon Sumitomo Company Details
  • Table Dainippon Sumitomo Description and Business Overview
  • Table Dainippon Sumitomo Respiratory drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Dainippon Sumitomo Respiratory drugs Sales Growth Rate (2013-2018)
  • Table Dainippon Sumitomo Respiratory drugs Sales Market Share in Global Market
  • Table Dainippon Sumitomo Recent Development
  • Table Abbott Company Details
  • Table Abbott Description and Business Overview
  • Table Abbott Respiratory drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Abbott Respiratory drugs Sales Growth Rate (2013-2018)
  • Table Abbott Respiratory drugs Sales Market Share in Global Market
  • Table Abbott Recent Development
  • Table Horizon Pharma Company Details
  • Table Horizon Pharma Description and Business Overview
  • Table Horizon Pharma Respiratory drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Horizon Pharma Respiratory drugs Sales Growth Rate (2013-2018)
  • Table Horizon Pharma Respiratory drugs Sales Market Share in Global Market
  • Table Horizon Pharma Recent Development
  • Table Amgen Company Details
  • Table Amgen Description and Business Overview
  • Table Amgen Respiratory drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Amgen Respiratory drugs Sales Growth Rate (2013-2018)
  • Table Amgen Respiratory drugs Sales Market Share in Global Market
  • Table Amgen Recent Development
  • Table Pfizer Company Details
  • Table Pfizer Description and Business Overview
  • Table Pfizer Respiratory drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Respiratory drugs Value Chain
  • Table Respiratory drugs Distributors List
  • Table Respiratory drugs Customers List
  • Table Global Respiratory drugs Sales Forecast 2018-2025 (K Units) & (Million US$)
  • Figure Global Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Figure Global Respiratory drugs Revenue Forecast 2018-2025 (Million US$)
  • Table Global Respiratory drugs Sales Forecast by Type 2018-2025 (K Units)
  • Figure Global Respiratory drugs Sales Forecast by Type 2018-2025 (K Units)
  • Figure Global Respiratory drugs Sales Market Share Forecast by Type 2018-2025
  • Table Global Respiratory drugs Sales Forecast by Application 2018-2025 (K Units)
  • Figure Global Respiratory drugs Sales Forecast by Application 2018-2025 (K Units)
  • Figure Global Respiratory drugs Sales Market Share Forecast by Application 2018-2025
  • Table Global Respiratory drugs Sales Forecast by Regions 2018-2025 (K Units)
  • Figure Global Respiratory drugs Sales Forecast by Regions 2018-2025 (K Units)
  • Figure Global Respiratory drugs Sales Market Share Forecast by Regions 2018-2025
  • Table Global Respiratory drugs Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Respiratory drugs Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Respiratory drugs Revenue Market Share Forecast by Regions 2018-2025
  • Table North America Respiratory drugs Sales Forecast by Countries 2018-2025 (K Units)
  • Table North America Respiratory drugs Sales Market Share Forecast by Countries 2018-2025
  • Table North America Respiratory drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table North America Respiratory drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure United States Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Figure Canada Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Figure MexicoRespiratory drugs Sales Forecast 2018-2025 (K Units)
  • Table Europe Respiratory drugs Sales Forecast by Countries 2018-2025 (K Units)
  • Table Europe Respiratory drugs Sales Market Share Forecast by Countries 2018-2025
  • Table Europe Respiratory drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Europe Respiratory drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure Germany Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Figure France Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Figure UK Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Figure Italy Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Figure Russia Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Table Asia Pacific Respiratory drugs Sales Forecast by Countries 2018-2025 (K Units)
  • Table Asia Pacific Respiratory drugs Sales Market Share Forecast by Countries 2018-2025
  • Table Asia Pacific Respiratory drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Asia Pacific Respiratory drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure China Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Figure Japan Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Figure Korea Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Figure India Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Figure Australia Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Figure Indonesia Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Figure Thailand Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Figure Malaysia Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Figure Philippines Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Figure Vietnam Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Table Central & South America Respiratory drugs Sales Forecast by Countries 2018-2025 (K Units)
  • Table Central & South America Respiratory drugs Sales Market Share Forecast by Countries 2018-2025
  • Table Central & South America Respiratory drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Central & South America Respiratory drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure Brazil Respiratory drugs Sales Forecast 2018-2025 (K Units)
  • Table Middle East and Africa Respiratory drugs Sales Forecast by Regions 2018-2025 (K Units)
  • Table Middle East and Africa Respiratory drugs Sales Market Share Forecast by Regions 2018-2025
  • Table Middle East and Africa Respiratory drugs Revenue Forecast by Regions 2018-2025 (Million US$)
  • Table Middle East and Africa Respiratory drugs Revenue Market Share Forecast by Regions 2018-2025
  • Figure GCC Countries Respiratory drugs Sales Growth Rate (2016-2025) (K Units)
  • Figure Egypt Respiratory drugs Sales Growth Rate (2016-2025) (K Units)
  • Figure South Africa Respiratory drugs Sales Growth Rate (2016-2025) (K Units)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
目次

This study researches the market size of Respiratory drugs, presents the global Respiratory drugs sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

This report focuses on the key data information of Respiratory drugs in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Respiratory drugs for each region and countries in each region.

For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Respiratory drugs are medicine used for respiratory deseases

In 2018, the global Respiratory drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Respiratory drugs.

This report includes the following manufacturers; we can also add the other companies as you want.

  • FibroGen
  • Amgen
  • Dr. Reddy's Laboratories
  • Afferent Pharmaceuticals
  • Dainippon Sumitomo
  • Abbott
  • Horizon Pharma
  • Amgen
  • Pfizer

Market Segment by Product Type

  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Idiopathic Pulmonary Fibrosis
  • Cystic Fibrosis

Market Segment by Application

  • Hospitals
  • Ambulatory Care
  • Others

Market size split by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Philippines
    • Thailand
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
    • Rest of Central & South America
  • Middle East & Africa
    • GCC Countries
    • Egypt
    • South Africa

The study objectives are:

  • To analyze and research the global Respiratory drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  • To present the key Respiratory drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
  • To split the breakdown data by regions, type, companies and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Respiratory drugs are as follows:

  • History Year: 2013-2018
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025

Table of Contents

1 Report Overview

  • 1.1 Research Scope
  • 1.2 Major Manufacturers Covered in This Report
  • 1.3 Market Segment by Type
    • 1.3.1 Global Respiratory drugs Market Size Growth Rate by Type
    • 1.3.2 Asthma
  • 1.4 Market Segment by Application
    • 1.4.1 Global Respiratory drugs Market Share by Application (2018-2025)
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Respiratory drugs Market Size
    • 2.1.1 Global Respiratory drugs Revenue 2013-2025
    • 2.1.2 Global Respiratory drugs Sales 2013-2025
  • 2.2 Respiratory drugs Growth Rate by Regions
    • 2.2.1 Global Respiratory drugs Sales by Regions 2013-2018
    • 2.2.2 Global Respiratory drugs Revenue by Regions 2013-2018
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers

3 Market Share by Manufacturers

  • 3.1 Respiratory drugs Sales by Manufacturers
    • 3.1.1 Respiratory drugs Sales by Manufacturers 2013-2018
    • 3.1.2 Respiratory drugs Sales Market Share by Manufacturers 2013-2018
  • 3.2 Revenue by Manufacturers
    • 3.2.1 Respiratory drugs Revenue by Manufacturers (2013-2018)
    • 3.2.2 Respiratory drugs Revenue Share by Manufacturers (2013-2018)
    • 3.2.3 Global Respiratory drugs Market Concentration Ratio (CR5 and HHI)
  • 3.3 Respiratory drugs Price by Manufacturers
  • 3.4 Key Manufacturers Respiratory drugs Plants/Factories Distribution and Area Served
  • 3.5 Date of Key Manufacturers Enter into Respiratory drugs Market
  • 3.6 Key Manufacturers Respiratory drugs Product Offered
  • 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Sales and Revenue for Each Type
    • 4.1.1 Asthma Sales and Revenue (2013-2018)
  • 4.2 Global Respiratory drugs Sales Market Share by Type
  • 4.3 Global Respiratory drugs Revenue Market Share by Type
  • 4.4 Respiratory drugs Price by Type

5 Market Size by Application

  • 5.1 Overview
  • 5.2 Global Respiratory drugs Sales by Application

6 North America

  • 6.1 North America Respiratory drugs Breakdown Data by Company
  • 6.2 North America Respiratory drugs Breakdown Data by Type
  • 6.3 North America Respiratory drugs Breakdown Data by Application
  • 6.4 North America Respiratory drugs Breakdown Data by Countries
    • 6.4.1 North America Respiratory drugs Sales by Countries
    • 6.4.2 North America Respiratory drugs Revenue by Countries
    • 6.4.3 United States
    • 6.4.4 Canada
    • 6.4.5 Mexico

7 Europe

  • 7.1 Europe Respiratory drugs Breakdown Data by Company
  • 7.2 Europe Respiratory drugs Breakdown Data by Type
  • 7.3 Europe Respiratory drugs Breakdown Data by Application
  • 7.4 Europe Respiratory drugs Breakdown Data by Countries
    • 7.4.1 Europe Respiratory drugs Sales by Countries
    • 7.4.2 Europe Respiratory drugs Revenue by Countries
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 UK
    • 7.4.6 Italy
    • 7.4.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Respiratory drugs Breakdown Data by Company
  • 8.2 Asia Pacific Respiratory drugs Breakdown Data by Type
  • 8.3 Asia Pacific Respiratory drugs Breakdown Data by Application
  • 8.4 Asia Pacific Respiratory drugs Breakdown Data by Countries
    • 8.4.1 Asia Pacific Respiratory drugs Sales by Countries
    • 8.4.2 Asia Pacific Respiratory drugs Revenue by Countries
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 Korea
    • 8.4.6 India
    • 8.4.7 Australia
    • 8.4.8 Indonesia
    • 8.4.9 Malaysia
    • 8.4.10 Philippines
    • 8.4.11 Thailand
    • 8.4.12 Vietnam

9 Central & South America

  • 9.1 Central & South America Respiratory drugs Breakdown Data by Company
  • 9.2 Central & South America Respiratory drugs Breakdown Data by Type
  • 9.3 Central & South America Respiratory drugs Breakdown Data by Application
  • 9.4 Central & South America Respiratory drugs Breakdown Data by Countries
    • 9.4.1 Central & South America Respiratory drugs Sales by Countries
    • 9.4.2 Central & South America Respiratory drugs Revenue by Countries
    • 9.4.3 Brazil

10 Middle East and Africa

  • 10.1 Middle East and Africa Respiratory drugs Breakdown Data by Type
  • 10.2 Middle East and Africa Respiratory drugs Breakdown Data by Application
  • 10.3 Middle East and Africa Respiratory drugs Breakdown Data by Countries
    • 10.3.1 Middle East and Africa Respiratory drugs Sales by Countries
    • 10.3.2 Middle East and Africa Respiratory drugs Revenue by Countries
    • 10.3.3 GCC Countries
    • 10.3.4 Egypt
    • 10.3.5 South Africa

11 Company Profiles

  • 11.1 FibroGen
    • 11.1.1 FibroGen Company Details
    • 11.1.2 Company Description and Business Overview
    • 11.1.3 Sales, Revenue and Market Share of Respiratory drugs
    • 11.1.4 Respiratory drugs Product Introduction
    • 11.1.5 FibroGen Recent Development
  • 11.2 Amgen
    • 11.2.1 Amgen Company Details
    • 11.2.2 Company Description and Business Overview
    • 11.2.3 Sales, Revenue and Market Share of Respiratory drugs
    • 11.2.4 Respiratory drugs Product Introduction
    • 11.2.5 Amgen Recent Development
  • 11.3 Dr. Reddy's Laboratories
    • 11.3.1 Dr. Reddy's Laboratories Company Details
    • 11.3.2 Company Description and Business Overview
    • 11.3.3 Sales, Revenue and Market Share of Respiratory drugs
    • 11.3.4 Respiratory drugs Product Introduction
    • 11.3.5 Dr. Reddy's Laboratories Recent Development
  • 11.4 Afferent Pharmaceuticals
    • 11.4.1 Afferent Pharmaceuticals Company Details
    • 11.4.2 Company Description and Business Overview
    • 11.4.3 Sales, Revenue and Market Share of Respiratory drugs
    • 11.4.4 Respiratory drugs Product Introduction
    • 11.4.5 Afferent Pharmaceuticals Recent Development
  • 11.5 Dainippon Sumitomo
    • 11.5.1 Dainippon Sumitomo Company Details
    • 11.5.2 Company Description and Business Overview
    • 11.5.3 Sales, Revenue and Market Share of Respiratory drugs
    • 11.5.4 Respiratory drugs Product Introduction
    • 11.5.5 Dainippon Sumitomo Recent Development
  • 11.6 Abbott
    • 11.6.1 Abbott Company Details
    • 11.6.2 Company Description and Business Overview
    • 11.6.3 Sales, Revenue and Market Share of Respiratory drugs
    • 11.6.4 Respiratory drugs Product Introduction
    • 11.6.5 Abbott Recent Development
  • 11.7 Horizon Pharma
    • 11.7.1 Horizon Pharma Company Details
    • 11.7.2 Company Description and Business Overview
    • 11.7.3 Sales, Revenue and Market Share of Respiratory drugs
    • 11.7.4 Respiratory drugs Product Introduction
    • 11.7.5 Horizon Pharma Recent Development
  • 11.8 Amgen
    • 11.8.1 Amgen Company Details
    • 11.8.2 Company Description and Business Overview
    • 11.8.3 Sales, Revenue and Market Share of Respiratory drugs
    • 11.8.4 Respiratory drugs Product Introduction
    • 11.8.5 Amgen Recent Development
  • 11.9 Pfizer
    • 11.9.1 Pfizer Company Details
    • 11.9.2 Company Description and Business Overview

12 Value Chain and Sales Channels Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Sales Channels Analysis
    • 12.2.1 Respiratory drugs Sales Channels
    • 12.2.2 Respiratory drugs Distributors
  • 12.3 Respiratory drugs Customers

13 Market Forecast

  • 13.1 Global Respiratory drugs Sales and Revenue Forecast 2018-2025
  • 13.2 Global Respiratory drugs Sales Forecast by Type
  • 13.3 Global Respiratory drugs Sales Forecast by Application
  • 13.4 Respiratory drugs Forecast by Regions
    • 13.4.1 Global Respiratory drugs Sales Forecast by Regions 2018-2025
    • 13.4.2 Global Respiratory drugs Revenue Forecast by Regions 2018-2025
  • 13.5 North America Market Forecast
    • 13.5.1 North America Respiratory drugs Forecast by Countries 2018-2025
    • 13.5.2 United States
    • 13.5.3 Canada
    • 13.5.4 Mexico
  • 13.6 Europe Market Forecast
    • 13.6.1 Europe Respiratory drugs Forecast by Countries 2018-2025
    • 13.6.2 Germany
    • 13.6.3 France
    • 13.6.4 UK
    • 13.6.5 Italy
    • 13.6.6 Russia
  • 13.7 Asia Pacific Market Forecast
    • 13.7.1 Asia Pacific Respiratory drugs Sales Forecast by Countries 2018-2025
    • 13.7.2 China
    • 13.7.3 Japan
    • 13.7.4 Korea
    • 13.7.5 India
    • 13.7.6 Australia
    • 13.7.7 Indonesia
    • 13.7.8 Thailand
    • 13.7.9 Malaysia
    • 13.7.10 Philippines
    • 13.7.11 Vietnam
  • 13.8 Central & South America Market Forecast
    • 13.8.1 Central & South America Respiratory drugs Sales Forecast by Countries 2018-2025
    • 13.8.2 Brazil
  • 13.9 Middle East and Africa Market Forecast
    • 13.9.1 Middle East and Africa Respiratory drugs Sales Forecast by Countries 2018-2025
    • 13.9.2 GCC Countries
    • 13.9.3 Egypt
    • 13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 15.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 13.1.2.2 Primary Sources
  • 15.2 Author Details
  • 15.3 Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.